Irene Ferrer Sánchez

Title: Irene Ferrer Sánchez: Innovator in Lung Cancer Treatment Prediction

Introduction

Irene Ferrer Sánchez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment, particularly in predicting patient responses to therapies. Her innovative work focuses on improving therapeutic decision-making for lung cancer patients.

Latest Patents

Irene holds a patent for a method involving N-cadherin and FGFR1 and/or FGFR4 for predicting the response of patients to lung cancer treatment. The patent describes a method for assessing how subjects suffering from lung cancer respond to FGFR inhibitors. By analyzing the expression of specific biomarkers, clinicians can classify patients as responsive or unresponsive to treatment. This classification aids in optimizing treatment plans, allowing unresponsive patients to receive alternative therapies.

Career Highlights

Throughout her career, Irene has worked with notable institutions such as Fundación de Investigación Hospital 12 de Octubre and Servicio Andaluz de Salud. Her experience in these organizations has contributed to her expertise in cancer research and treatment methodologies.

Collaborations

Irene has collaborated with esteemed colleagues, including Luis Paz-Ares Rodríguez and Álvaro Quintanal Villalonga. These partnerships have furthered her research and development efforts in the field of oncology.

Conclusion

Irene Ferrer Sánchez is a trailblazer in the realm of lung cancer treatment, with her innovative patent paving the way for more effective patient care. Her work exemplifies the importance of research and collaboration in advancing medical science.